Literature DB >> 8981777

Synergy of human neutrophils with fluconazole in killing Candida species.

E Brummer1, D A Stevens.   

Abstract

The killing of Candida species by human neutrophils in a long-term 24-h assay and possible synergy with fluconazole (FCZ) for killing was investigated. The test medium (TM) consisted of RPMI-1640, penicillin and streptomycin (P/S), and 10% fresh autologous serum. TM alone was highly fungistatic for Candida species compared to TM without serum. When neutrophils were cocultured in TM with Candida species for 24 h the inoculum colony-forming units (CFU) were always significantly reduced (killing) by 58 to 99%. FCZ was tested over a range of 1-500 micrograms/ml, and though almost always fungistatic itself, it synergized with neutrophils for significantly increased killing of C. albicans (isolate Sh27) (P < 0.01) and C. albicans (isolate 94-20) (P < 0.05). Killing of non-albicans Candida species was so efficient in the absence of FCZ that demonstration of synergy with FCZ was difficult.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8981777     DOI: 10.1007/bf00436717

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  16 in total

1.  Impaired neutrophil function in patients with AIDS or AIDS-related complex: a comprehensive evaluation.

Authors:  M Ellis; S Gupta; S Galant; S Hakim; C VandeVen; C Toy; M S Cairo
Journal:  J Infect Dis       Date:  1988-12       Impact factor: 5.226

2.  Comparison of candidacidal and candidastatic activities of human neutrophils.

Authors:  P G Sohnle; C Collins-Lech
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

3.  High dose oral fluconazole for oropharyngeal candidosis in AIDS.

Authors:  A M Ansari; I M Gould; J G Douglas
Journal:  J Antimicrob Chemother       Date:  1990-04       Impact factor: 5.790

4.  Fungal infections complicating acute leukemia.

Authors:  G P Bodey
Journal:  J Chronic Dis       Date:  1966-06

5.  Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome.

Authors:  R S Klein; C A Harris; C B Small; B Moll; M Lesser; G H Friedland
Journal:  N Engl J Med       Date:  1984-08-09       Impact factor: 91.245

6.  Effects of antifungal agents on the function of human neutrophils in vitro.

Authors:  E Roilides; T J Walsh; M Rubin; D Venzon; P A Pizzo
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

7.  Effects of azole antifungals in vitro on host/parasite interactions relevant to Candida infections.

Authors:  F C Odds; C E Webster
Journal:  J Antimicrob Chemother       Date:  1988-10       Impact factor: 5.790

Review 8.  Infectious complications of human bone marrow transplantation.

Authors:  D J Winston; R P Gale; D V Meyer; L S Young
Journal:  Medicine (Baltimore)       Date:  1979-01       Impact factor: 1.889

9.  Effect of fluconazole on the interactions between human neutrophils and Candida albicans.

Authors:  A M Sugar; J Tjia
Journal:  Int J Antimicrob Agents       Date:  1993       Impact factor: 5.283

10.  Opposite effects of human monocytes, macrophages, and polymorphonuclear neutrophils on replication of Blastomyces dermatitidis in vitro.

Authors:  E Brummer; D A Stevens
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

View more
  5 in total

1.  Activity of voriconazole, a new triazole, combined with neutrophils or monocytes against Candida albicans: effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.

Authors:  S Vora; N Purimetla; E Brummer; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

2.  Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates.

Authors:  M E Kuipers; H G de Vries; M C Eikelboom; D K Meijer; P J Swart
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

3.  Effect of granulocyte colony-stimulating factor on the candidacidal activity of polymorphonuclear neutrophils and their collaboration with fluconazole.

Authors:  U Natarajan; E Brummer; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

4.  Activity of voriconazole combined with neutrophils or monocytes against Aspergillus fumigatus: effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.

Authors:  S Vora; S Chauhan; E Brummer; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

Review 5.  Animal models of zygomycosis--Absidia, Rhizopus, Rhizomucor, and Cunninghamella.

Authors:  K Kamei
Journal:  Mycopathologia       Date:  2001       Impact factor: 3.785

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.